Table 1.
Summary of meta-analyses on the safety profile of brainstem biopsy in children.
| Meta- Analysis Study | Details of component studies | Key Findings | Comments |
|---|---|---|---|
| Kickingereder 2013 (27) | Included both adult and children, mean age 29 years. N = 1480 total cases. All stereotactic, 68% transfrontal approach. | 96.2% diagnostic success, 7.8% overall morbidity (95% CI 5.6-10.2), 1.7% permanent morbidity (95% CI 0.9-2.7), 0.9% mortality (95% CI 0.5-1.4). Biopsy trajectory had no influence on outcome measures. | Widely cited due to large pooled sample size but with the significant limitation that adults and children are combined for analysis. |
| Hamisch 2017 (28) | N = 735 children, mean age 8 years, all stereotactic, 60% transfrontal. Included studies from 1993-2015. | 96.1 diagnostic success, 6.7% overall morbidity (95% CI 4.2-9.6), 0.6% permanent morbidity (95% CI 0.2-1.4), 0.6% mortality (95% CI 0.2-1.3). Biopsy trajectory had no influence on outcome measures. | Large pediatric-only cohort, about a third of studies are from 1980s-1990s so unclear if they reflect contemporary practice. No clear description of what the specific morbidities encountered in component studies and aggregated in the meta-analysis were. |
| Fu 2023 (29) | N = 381 cases, all patients <21 years of age, only included patients with suspected diffuse midline glioma. | For biopsies in general: 11% overall morbidity (95% CI 4.8-18.9), 0.3% permanent morbidity (95% CI 0-2.2), 3 mortalities in the total cohort (0.8%). For stereotactic biopsies: 5.3% overall morbidity (95 CI: 1.5 – 10.7), 0% permanent morbidity (95% CI 0-1.1), no deaths | Highly selective inclusion criteria resulting in a focused analysis for pediatric suspected DMG cases, though with smaller pooled sample size. |
| Lu 2023 (30) | N = 99 cases, all children with mean age 9 years, all patients had stereotactic, frameless, robot-assisted biopsy | Transient complications: 10% (95% CI: 4-19%), permanent complications 0% (95% CI 0-2%), no deaths | This study describes a pediatric-only population undergoing brainstem biopsy with a cutting-edge technique (frameless, robotic stereotaxy). |
| Sheikh 2024 (31) | N=1002 children, 87% stereotactic. | Transient complications: 6% (95% CI 4-8), permanent complications 1% (95% CI 0.5-2). 5 mortalities in total. | Largest pooled cohort of pediatric cases. Included only contemporary series (2003-2023). Most common transient neurological complications were: 1) cranial nerve dysfunction, 2) worsening or new ataxia, 3) limb weakness. Most common permanent complications were: 1) cranial nerve dysfunction, 2) limb weakness. |